Voyager Acquisition Corp./Cayman Islands
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
Cayman Islands
Business Address
C/O WINSTON & STRAWN LLP, HOUSTON, TX, 77002
Mailing Address
C/O WINSTON & STRAWN LLP, HOUSTON, TX, 77002
Phone
03477204333
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K/A Annual report amendment | April 2, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 10-K Annual financial report | March 10, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 10, 2026 | View on SEC |
| 8-K Current report of material events | February 3, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 21, 2025 | View on SEC |
Annual Reports
10-K
March 10, 2026
- Successful IPO on August 12, 2024, raising $253 million, with $255 million now held in the trust account.
- Definitive agreement to merge with Veraxa Biotech AG, a clinical-stage biotechnology company focused on novel therapeutic antibodies for oncology and autoimmune diseases.
Material Events
8-K
Acquisition
March 18, 2026
High Impact
- Shareholder approval secured for Voyager Acquisition Corp.'s merger with Veraxa Biotech AG.
- Voyager Acquisition Corp. will transform into Veraxa Biotech Holding AG, with Veraxa Biotech AG becoming its wholly-owned subsidiary.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.